Jennison Associates LLC Pacira Bio Sciences, Inc. Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$30.68 - $40.09 $10.5 Million - $13.8 Million	-343,751 Reduced 35.61%	621,679 $19.1 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $47.5 $5.04 Million - $6.63 Million	139,593 Added 16.9%	965,430 $38.7 Million
Q1 2023 Apr 26, 2023	SELL	$35.53 - $43.38 $336,398 - $410,721	-9,468 Reduced 1.13%	825,837 $33.7 Million
Q4 2022 Feb 09, 2023	BUY	$38.19 - $57.45 $1.46 Million - $2.2 Million	38,254 Added 4.8%	835,305 $32.3 Million
Q3 2022 Nov 01, 2022	BUY	$51.24 - $58.89 $19.6 Million - $22.5 Million	382,680 Added 92.35%	797,051 $42.4 Million
Q2 2022 Aug 02, 2022	BUY	$51.49 - $81.64 $21.3 Million - $33.8 Million	414,371 New	414,371 $24.2 Million
Q2 2018 Aug 02, 2018	SELL	$27.5 - $39.8 $14.2 Million - $20.5 Million	-515,132 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$29.98 - $46.35 $15.4 Million - $23.9 Million	515,132 New	515,132 $16 Million

266

50.6M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $761M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.